glp 1 agonist full form GLP-1 Agonists GLP-1 Agonists for Addiction

To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management

These medications are generally recommended for individuals who are overweight or obese, especially if they have additional health risks like type 2 diabetes or metabolic syndrome

Obes Rev 9(5):489500 Dalle Grave R, Calugi S, El Ghoch M (2013) Lifestyle modification in the management of obesity: achievements and challenges

Semaglutide GLP-1, a groundbreaking medication initially developed for type 2 diabetes, is now available at our practice as part of our weight management program due to its remarkable effectiveness in promoting weight loss

Further, warnings on GLP-1RAs have recently been strengthened over rare cases of necrotising and fatal pancreatitis following use